Pfizer Faces Revenue Decline and Patent Cliffs, but New Deals and Acquisitions Offer a Path Forward

Pfizer Inc. reported a 1.6% drop in 2025 revenue to $62.6 billion, a sharp decline from the $100 billion peak reached in...

Read story →